About Stereotaxis

“One of the most beneficial aspects of the Stereotaxis system, I believe, is the idea of drastically reducing radiation exposure to both patient and physician. In addition, a significant clinical advantage resides in the ability to utilize a computer to produce micro catheter movements that would be very difficult to execute manually. These micro movements are made possible by the Stereotaxis system, which we have found to be superior to manual navigation.”

Gery Tomassoni, MD
Lexington Cardiology Consultants
Central Baptist Hospital
Lexington, KY

Stereotaxis’ comprehensive range of proprietary products and solutions, which are built around the technology of magnetics, have introduced a new era in cardiac interventional medicine. This era is one in which physicians are able to safely and remotely perform computerized catheter-based interventional procedures. Physicians are able to conduct these procedures using a range of “point and click”, “joystick”, “push button” and “touch screen” modes, from the control room adjacent to the patient lab, or cath lab, and outside the x-ray field that is used for all types of interventional procedures. Physicians may use partial or full automation of procedure protocols through the use of customized software. Products are designed to provide patients with enhanced outcomes, safety and access to important new therapies, as well as to improve hospital’s cath lab efficiencies and to improve physician safety, comfort and ease of use relative to conventional interventional methods.

Focused on major cardiology applications, Stereotaxis’ computerized magnetic procedures are conducted with full digital integration of the major imaging and other technologies in the cath lab. The result is that, for the first time in the history of interventional medicine, physicians are provided with seamless access to highly integrated state-of-the-art imaging and precise remote instrument control. We have achieved this technology integration by working with our alliance partners, including Biosense Webster, a Johnson & Johnson Company, Siemens, Philips and other important cath lab technology providers.

Stereotaxis’ goal is to provide patients and their physicians with safe and effective, least invasive interventional solutions for complex and routine cardiology applications, by establishing magnetic, computerized treatment as a new standard of care.

Arrhythmias: interventional electrophysiology diagnosis and treatment of complex arrhythmias such as atrial fibrillation and atrial flutter, as well as common arrhythmias such as supraventricular tachycardias.
Heart Failure: interventional procedures primarily for cardiac resynchronization therapy
Coronary Artery Disease: interventional procedures for reopening blocked arteries in coronary vessels with partial occlusions or chronic total occlusion

The key components of Stereotaxis’ product platform have received appropriate regulatory clearances and approvals and are widely available worldwide.

	NIOBE® Magnetic Navigation System, that provides precise navigation and control of the working end of proprietary disposables catheters and guidewires
	Proprietary Magnetically Enabled GentleTouch Catheters, Guidewires and Other Disposables Devices that are used to deliver therapy
	A Sophisticated User-Friendly Interface, The Proprietary Navigant™ Software User Interface, through which the physician conducts the procedure from the control room adjacent to the cath lab, outside the x-ray field. This user interface is digitally integrated with the other key cath lab imaging technologies
	Proprietary Software to facilitate specific complex procedure types and protocols
	A Comprehensive Service and Maintenance Program

The Company designs, manufactures and markets its own products directly. In addition, a range of magnetically enabled ablation and mapping catheters is manufactured and marketed by Biosense Webster, Inc., a Johnson & Johnson company.

Stereotaxis is highly focused on providing comprehensive training to the physicians and healthcare providers who use our products. Providing product solutions in the areas of our clinical focus is a dynamic process. We are constantly developing new devices, software, and procedure solutions that provide important benefits for patients, hospitals, and physicians.

Customers include both leading research-oriented institutions in interventional medicine worldwide and more commercially oriented, high volume sites. Stereotaxis’ technology has received the endorsement of thought-leader clinicians in electrophysiology ablation, cardiac resynchronization therapy and interventional cardiology.